Wells Fargo’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36K | Buy |
1,688
+1,686
| +84,300% | +$2.36K | ﹤0.01% | 5739 |
|
|
2025
Q1 | $4 | Buy |
+2
| New | +$4 | ﹤0.01% | 6436 |
|
|
2024
Q4 | – | Sell |
-9,544
| Closed | -$33.8K | – | 6650 |
|
|
2024
Q3 | $33.8K | Buy |
+9,544
| New | +$33.8K | ﹤0.01% | 5090 |
|
|
2024
Q2 | – | Sell |
-31
| Closed | -$206 | – | 7066 |
|
|
2024
Q1 | $206 | Buy |
31
+4
| +15% | +$27 | ﹤0.01% | 6096 |
|
|
2023
Q4 | $82 | Buy |
27
+3
| +13% | +$9 | ﹤0.01% | 6373 |
|
|
2023
Q3 | $36 | Hold |
24
| – | – | ﹤0.01% | 6639 |
|
|
2023
Q2 | $43 | Buy |
24
+1
| +4% | +$2 | ﹤0.01% | 6789 |
|
|
2023
Q1 | $29 | Hold |
23
| – | – | ﹤0.01% | 6956 |
|
|
2022
Q4 | $55 | Buy |
23
+1
| +5% | +$2 | ﹤0.01% | 6652 |
|
|
2022
Q3 | $0 | Hold |
22
| – | – | ﹤0.01% | 7199 |
|
|
2022
Q2 | $0 | Buy |
22
+2
| +10% | – | ﹤0.01% | 7300 |
|
|
2022
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 7368 |
|
|
2021
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 7347 |
|
|
2021
Q3 | $0 | Sell |
20
-3
| -13% | – | ﹤0.01% | 7256 |
|
|
2021
Q2 | $1K | Buy |
23
+2
| +10% | +$87 | ﹤0.01% | 6419 |
|
|
2021
Q1 | $1K | Buy |
21
+14
| +200% | +$667 | ﹤0.01% | 6406 |
|
|
2020
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 6751 |
|
|
2020
Q3 | $0 | Buy |
7
+4
| +133% | – | ﹤0.01% | 6605 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 6505 |
|
|
2020
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 6477 |
|
|
2018
Q2 | – | Sell |
-42
| Closed | -$7K | – | 6078 |
|
|
2018
Q1 | $7K | Hold |
42
| – | – | ﹤0.01% | 5615 |
|
|
2017
Q4 | $9K | Buy |
42
+26
| +163% | +$5.57K | ﹤0.01% | 5567 |
|
|
2017
Q3 | $4K | Buy |
+16
| New | +$4K | ﹤0.01% | 5680 |
|